SN-NNS2 Hydrogen Inhalation System
Advanced molecular hydrogen therapy with nasal inhalation technology
Multiple configurations for every application
The SN-NNS2 system delivers high-purity molecular hydrogen through advanced SPE technology. Available in three form factors: portable bottle adapter, desktop generator, and compact inhaler with nasal delivery tube.
Each unit features a distinctive blue LED ring indicating active hydrogen production, ensuring visual confirmation of system operation.
Model EHM-H13
Precision engineering for optimal performance
The desktop model features a transparent borosilicate glass chamber for visual monitoring of the electrolysis process. Anodized aluminum construction with ABS and Tritan components ensures durability and safety.
Technical Overview
Advanced specifications across all parameters
| Parameter | Specification |
|---|---|
| Product Model | SN-NNS2 / EHM-H13 |
| Hydrogen Production Method | SPE Proton Exchange Membrane Electrolysis |
| Hydrogen Concentration | 3000-4500 ppb (≥99.995% purity), ±10% |
| Production Rate | ≥450 mL/min |
| Operating Temperature | 0°C to 80°C |
| Material Composition | Aluminum Alloy (Anodized) + ABS + Tritan™ |
| Power Requirements | DC 3.7V / 1800mAh (USB-C compatible) |
| Electrolysis Technology | SPE with platinum-coated titanium electrodes |
| Dimensions (Desktop Model) | Φ63mm × 193mm (2.5" × 7.6") |
| Weight | 0.54 kg (1.2 lbs), ±5% |
Note: All specifications tested under standard laboratory conditions. Performance may vary based on water quality and environmental factors.
Source: HydroTech Laboratory Testing; Independent verification by certified facilities
Chapter 1
SPE technology and molecular hydrogen delivery
SPE Electrolysis
Solid Polymer Electrolyte membrane ensures complete separation of hydrogen and oxygen during electrolysis, preventing ozone formation and achieving 99.995% purity.
Safety Engineering
Dual pressure relief system with automatic shutoff protection. Food-grade Tritan™ construction meets stringent safety standards for all ages.
Nasal Delivery
Direct nasal delivery bypasses hepatic metabolism, enabling superior bioavailability through the extensive vascular network of nasal mucosa.
Chapter 2
Scientific foundation and clinical evidence
Selective antioxidant mechanism
Molecular hydrogen (H₂) selectively neutralizes cytotoxic oxygen radicals including hydroxyl radical (•OH) and peroxynitrite (ONOO⁻), while preserving beneficial reactive oxygen species essential for cellular signaling. This selectivity distinguishes H₂ from conventional antioxidants.
Enhanced bioavailability through nasal inhalation
The nasal inhalation pathway provides direct systemic distribution through the rich capillary network of the nasal mucosa, bypassing first-pass hepatic metabolism. Studies demonstrate superior bioavailability compared to oral hydrogen-rich water consumption.
Clinical Research Validation
1000+
Peer-reviewed publications documenting therapeutic potential across metabolic disorders, neurodegenerative conditions, and inflammatory diseases. Human clinical trials demonstrate excellent safety profiles with 60-80% showing positive therapeutic outcomes.
Research Data Unavailable
Unable to load additional research data at this time.
Experience molecular hydrogen therapy
SN-NNS2 Hydrogen Inhalation System — Available now at ₹8,000